BARCLAYS PLC - VOYAGER THERAPEUTICS INC ownership

VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 84 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$141
+95.8%
18,309
+188.8%
0.00%
Q2 2023$72
-73.6%
6,339
-82.1%
0.00%
Q1 2023$273
+190.4%
35,436
+129.2%
0.00%
Q4 2022$94
-99.1%
15,461
+714.6%
0.00%
Q3 2022$11,000
+22.2%
1,898
-45.5%
0.00%
Q3 2021$9,000
-71.0%
3,483
-53.2%
0.00%
Q2 2021$31,000
-69.9%
7,444
-65.8%
0.00%
Q1 2021$103,000
+71.7%
21,756
+154.9%
0.00%
Q4 2020$60,000
-52.8%
8,534
-28.3%
0.00%
Q3 2020$127,000
-40.9%
11,907
-30.0%
0.00%
Q2 2020$215,000
+162.2%
17,002
+88.5%
0.00%
Q1 2020$82,000
-77.0%
9,018
-64.7%
0.00%
Q4 2019$356,000
-30.1%
25,535
-13.6%
0.00%
Q3 2019$509,000
-40.5%
29,569
-5.8%
0.00%
-100.0%
Q2 2019$855,000
+600.8%
31,397
+393.0%
0.00%
Q1 2019$122,000
+6000.0%
6,368
+3068.2%
0.00%
Q4 2018$2,000
-99.4%
201
-98.9%
0.00%
Q3 2018$347,000
+5.2%
18,299
+8.5%
0.00%
Q2 2018$330,000
-46.1%
16,869
-48.2%
0.00%
Q1 2018$612,000
+35.7%
32,577
+19.9%
0.00%
Q4 2017$451,000
+49.8%
27,162
+85.6%
0.00%
Q3 2017$301,000
+238.2%
14,637
+47.7%
0.00%
Q2 2017$89,000
-25.2%
9,911
+10.7%
0.00%
Q1 2017$119,000
+417.4%
8,954
+397.4%
0.00%
Q4 2016$23,000
+2200.0%
1,800
+2332.4%
0.00%
Q3 2016$1,000740.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 6,391,176$45,697,0003.92%
ARMISTICE CAPITAL, LLC 3,392,000$24,253,0000.82%
Bellevue Group AG 2,712,083$19,391,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 141,924$1,015,0000.17%
XTX MARKETS LLC 10,578$76,0000.16%
Aevitas Wealth Management, Inc. 22,150$158,0000.12%
Virtus ETF Advisers LLC 35,079$251,0000.10%
HITE Hedge Asset Management LLC 29,357$210,0000.05%
LINCOLN CAPITAL CORP 10,000$72,0000.05%
CIM INVESTMENT MANAGEMENT INC 18,745$134,0000.04%
View complete list of VOYAGER THERAPEUTICS INC shareholders